Medicine
Acyclovir 400 mg tablet
Acyclovir 400 mg tablet is a generic prescription medicine for oral use, made by 30 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted from 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Acyclovir
- Brand
- Sold under the generic name
- Strength
- 400 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 30 tablets and 219 more
- Manufacturers
- Zydus LifesciencesIndiaAurobindo PharmaIndiaAvet PharmaceuticalsIndiaCadila PharmaceuticalsIndiaCamber PharmaceuticalsIndiaPharmPakSquare PharmaceuticalsBionpharmaCarlsbad TechnologyModavar Pharmaceuticals30 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted from 15° to 30°C (59° to 86°F) and protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D06BB03 Acyclovir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 March 1999
- Identifiers
- RxCUI 197311, 197313DailyMed set ID e186fdc9-b60e-4280-8d60-36cae9f2838f, 0de2f5c7-9e75-4bdf-9c28-e026cc6694b4, f3e6b1ad-810b-4f53-b92a-b28fc2111f3f +37NDC 76420-050, 23155-227, 50090-3254 +37Application ANDA077309, ANDA074891, ANDA204314 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 30 labelers. The register lists 222 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 65841-802-01 | Zydus LifesciencesIndia | 10 September 2014 |
| 500 tablet in 1 bottle | 65841-802-05 | Zydus LifesciencesIndia | 10 September 2014 |
| 30 tablet in 1 bottle | 65841-802-06 | Zydus LifesciencesIndia | 10 September 2014 |
| 1000 tablet in 1 bottle | 65841-802-10 | Zydus LifesciencesIndia | 10 September 2014 |
| 90 tablet in 1 bottle | 65841-802-16 | Zydus LifesciencesIndia | 10 September 2014 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 65841-802-30 | Zydus LifesciencesIndia | 10 September 2014 |
| 100 tablet in 1 bottle | 68382-791-01 | Zydus LifesciencesIndia | 10 September 2014 |
| 500 tablet in 1 bottle | 68382-791-05 | Zydus LifesciencesIndia | 10 September 2014 |
| 30 tablet in 1 bottle | 68382-791-06 | Zydus LifesciencesIndia | 10 September 2014 |
| 1000 tablet in 1 bottle | 68382-791-10 | Zydus LifesciencesIndia | 10 September 2014 |
| 90 tablet in 1 bottle | 68382-791-16 | Zydus LifesciencesIndia | 10 September 2014 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 68382-791-30 | Zydus LifesciencesIndia | 10 September 2014 |
| 100 tablet in 1 bottle | 59651-965-01 | Aurobindo PharmaIndia | 11 September 2025 |
| 500 tablet in 1 bottle | 59651-965-05 | Aurobindo PharmaIndia | 11 September 2025 |
| 10 tablet in 1 bottle | 59651-965-10 | Aurobindo PharmaIndia | 11 September 2025 |
| 100 tablet in 1 bottle | 23155-227-01 | Avet PharmaceuticalsIndia | 8 August 2013 |
| 500 tablet in 1 bottle | 23155-227-05 | Avet PharmaceuticalsIndia | 8 August 2013 |
| 100 tablet in 1 bottle | 71209-005-05 | Cadila PharmaceuticalsIndia | 20 November 2018 |
| 500 tablet in 1 bottle | 71209-005-10 | Cadila PharmaceuticalsIndia | 20 November 2018 |
| 100 tablet in 1 bottle | 31722-777-01 | Camber PharmaceuticalsIndia | 29 November 2013 |
| 500 tablet in 1 bottle | 31722-777-05 | Camber PharmaceuticalsIndia | 29 November 2013 |
| 100 tablet in 1 bottle | 60505-5306-1 | Apotex | 9 June 2007 |
| 100 tablet in 1 bottle | 69452-290-20 | Bionpharma | 15 August 2020 |
| 500 tablet in 1 bottle | 69452-290-30 | Bionpharma | 15 August 2020 |
| 24 bottle, plastic in 1 box / 100 tablet in 1 bottle, plastic | 61442-112-01 | Carlsbad Technology | 24 January 2020 |
| 12 bottle, plastic in 1 box / 500 tablet in 1 bottle, plastic | 61442-112-05 | Carlsbad Technology | 24 January 2020 |
| 100 tablet in 1 bottle | 72241-026-05 | Modavar Pharmaceuticals | 18 August 2021 |
| 500 tablet in 1 bottle | 72241-026-10 | Modavar Pharmaceuticals | 18 August 2021 |
| 1 bottle in 1 box / 10 tablet in 1 bottle | 54348-627-10 | PharmPak | 8 August 2019 |
| 1 bottle in 1 box / 15 tablet in 1 bottle | 54348-627-15 | PharmPak | 8 August 2019 |
| 1 bottle in 1 box / 20 tablet in 1 bottle | 54348-627-20 | PharmPak | 8 August 2019 |
| 1 bottle in 1 box / 21 tablet in 1 bottle | 54348-627-21 | PharmPak | 8 August 2019 |
| 1 bottle in 1 box / 25 tablet in 1 bottle | 54348-627-25 | PharmPak | 8 August 2019 |
| 1 bottle in 1 box / 30 tablet in 1 bottle | 54348-627-30 | PharmPak | 8 August 2019 |
| 1 bottle in 1 box / 60 tablet in 1 bottle | 54348-627-60 | PharmPak | 8 August 2019 |
| 30 tablet in 1 bottle | 76483-047-00 | Square Pharmaceuticals | 31 January 2020 |
| 100 tablet in 1 bottle | 76483-047-04 | Square Pharmaceuticals | 31 January 2020 |
| 500 tablet in 1 bottle | 76483-047-05 | Square Pharmaceuticals | 31 January 2020 |
| 100 tablet in 1 bottle | 69117-0018-1 | Yiling Pharmaceutical | 4 May 2018 |
| 500 tablet in 1 bottle | 69117-0018-2 | Yiling Pharmaceutical | 4 May 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 March 1982 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Acyclovir
Clinical summary
Acyclovir is a herpes simplex virus nucleoside analog DNA polymerase inhibitor indicated in the management of initial genital herpes and in limited non-lifethreatening mucocutaneous HSV infections in immunocompromised patients. MedsAcross supplies Acyclovir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AcyclovirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zovirax prescribing information (Bausch Health) · U.S. National Library of Medicine, DailyMed
Need Acyclovir 400 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.